Lack of effect on ambulation of dalfampridine-ER (4-AP) treatment in adult SMA patients is a research paper published in Neuromuscular Disorders (2020). On theSindex it has a DataRank of 0. It has been cited 16 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph β no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full β never from an abstract alone.
U.S. Department of Defense
Grant: W81XWH-11β10753
National Institutes of Health
Grant: UL1TR000040
National Center for Advancing Translational Sciences
FWCI
1.01
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals